SCHEMBL824405

SCHEMBL824405

CSOON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14142074 0.71
SCHEMBL824461 0.67
SCHEMBL11933941 0.61
SCHEMBL12369367 0.60
SCHEMBL14462017 0.58
SCHEMBL1255009 0.51
SCHEMBL145076 0.51
SCHEMBL141709 0.51
SCHEMBL7648923 0.50
SCHEMBL14545108 0.48

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8865895-B2 Organic compound, anisotropic optical film and method of production thereof CRYSOPTIX K.K. (JP) 2014-10-21 US disclosed
US-8416376-B2 Compensated in-plane switching mode liquid crystal display CRYSOPTIX KK (JP) 2013-04-09 US disclosed
US-8142863-B2 Color liquid crystal display and compensation panel Crysoptix, KK (JP) 2012-03-27 US disclosed
US-7889297-B2 Liquid crystal display operating in a vertically aligned mode Crysoptix, KK (JP) 2011-02-15 US disclosed
US-20100149471-A1 Compensated In-Plane Switching Mode Liquid Crystal Display CRYSOPTIX KK (JP) 2010-06-17 US disclosed
US-20100118241-A1 Liquid Crystal Display Operating in a Vertically Aligned Mode CRYSOPTIX KK (JP) 2010-05-13 US disclosed
US-20100039705-A1 Organic Compound, Anisotropic Optical Film and Method of Production Thereof CRYSOPTIX KK (JP) 2010-02-18 US disclosed
US-7648997-B2 Immunomodulators for inducing cytokine biosynthesis, for treatment of diseases including viral and neoplastic diseases; 1-[3-(Aminooxy)propyl]-2-propyl-1H-imidazo[4,5-c]quinolin-4-amine; N-[3-(4-Amino-2-propyl-1H-imidazo[4,5-c]quinolin-1-yl)propoxy]cyclopropanecarboxamide COLEY PHARMACEUTICAL GROUP, INC. (US) 2010-01-19 US disclosed
US-20090268136-A1 Color Liquid Crystal Display and Compensation Panel CRYSOPTIX KK (JP) 2009-10-29 US disclosed
US-20090191394-A1 Oarganic Compound, Optical Crystal Film and Method of Production Thereof CRYSOPTIX K.K. (JP) 2009-07-30 US disclosed
US-20080114019-A1 Hydroxylamine Substituted Imidazoquinolines COLEY PHARMACEUTICAL GROUP, INC. (US) 2008-05-15 US disclosed
US-7332267-B2 Photothermographic material FUJIFILM CORPORATION (JP) 2008-02-19 US disclosed
US-7314706-B2 Photothermographic material and manufacturing method FUJIFILM CORPORATION (JP) 2008-01-01 US disclosed
US-7291448-B2 Photothermographic material FUJIFILM CORPORATION (JP) 2007-11-06 US disclosed
US-20070224555-A1 Photothermographic material FUJIFILM CORPORATION 2007-09-27 US disclosed
US-20070207417-A1 Photothermographic material FUJIFILM CORPORATION 2007-09-06 US disclosed
US-7226728-B2 Photothermographic material FUJIFILM CORPORATION (JP) 2007-06-05 US disclosed
US-20070072136-A1 Photothermographic material FUJI PHOTO FILM CO., LTD. 2007-03-29 US disclosed
US-20070015095-A1 Photothermographic material FUJI PHOTO FILM CO., LTD. 2007-01-18 US disclosed
US-7157220-B2 Silver halide photosensitive material and photothermographic material FUJIFILM CORPORATION (JP) 2007-01-02 US disclosed